Radiology group Radisphere pulls in $10M in equity

Radisphere has landed a $10 million equity investment as the radiology company looks to expand its community hospital customer base.Radiology outsourcing groups like Cleveland-area Radisphere have become increasingly popular with investors in recent years. The trend is being driven largely by technology advances and healthcare cost pressures, which have combined to create a lucrative market [...]

[Read more of this report]


Is the early stage funding valley of death a myth?

You can’t read much about the venture capital industry before you start hearing about the so-called “valley of death” for early stage companies.Conventional wisdom holds that young companies enter that valley, in which attracting investment capital becomes extremely difficult, at an early stage, typically between an initial round of angel funding and the company’s first [...]

[Read more of this report]


CWRU researchers: Drug shows promise in reducing Alzheimer’s plaque in brain

A drug that’s already approved by the FDA has shown promise in clearing away a plaque in the brain that’s associated with Alzheimer’s disease, Case Western Reserve University researchers have found.The drug, bexarotene (brand name Targretin), in mice was able to reduce levels of Beta-amyloid plaque, a protein fragment that builds up in the brains [...]

[Read more of this report]


Intravenous device company lands first major customer

A startup that’s developed a device to better secure intravenous lines has landed its first major customer.Linebacker said winning its first big client would help the startup build credibility for its eponymous product and expand to other healthcare systems, according to a statement from the Columbus-area company.The company didn’t have to look far for the [...]

[Read more of this report]


Are more than 10 percent of doctors liars? Survey says, ‘yes’

About 11 percent of doctors have knowingly lied to a patient in the last year, according to a new survey published in Health Affairs.Reasons why doctors lie to patients vary. Nearly 20 percent of physicians said they had not fully disclosed an error to a patient due to fear of malpractice litigation. More than 55 [...]

[Read more of this report]


Cleveland Clinic Innovations executive still dogged by Kansas controversy

An executive hired last year by Cleveland Clinic Innovations was faulted for destroying documents, misusing public funds for personal expenses and creating an uncomfortable work environment by having an office romance in his previous job at a Kansas economic development group, according to a recently released audit by the state of Kansas.However, the $960,000, 900-page [...]

[Read more of this report]


Neurostimulation company Checkpoint raises $1.7M, looks to CE Mark

Neurostimulation company Checkpoint Surgical has raised a $1.7 million series B round of investment and expects to win European regulatory approval of its intraoperative device shortly.The Cleveland-area company will use the new funding to boost its U.S. sales and marketing staff, CEO Len Cosentino said.var page_count = “off”; [...]

[Read more of this report]


Does $100M Cleveland Bio Fund have a future after CEO’s indictment?

The chief executive of what was touted as a $100 million investment fund aimed in part at Ohio medical device companies has been indicted for his alleged role in the failure of a suburban Cleveland credit union.The indictment of 43-year-old businessman Eddy Zai, who was charged with 34 counts related to more than $16 million [...]

[Read more of this report]


Navidea Biopharmaceuticals opens Boston commercialization office

Radiopharmaceuticals company Navidea Biopharmaceuticals (NYSE Amex:NAVB) has opened a Boston-area commercialization office.Employees at Navidea’s new Andover, Massachusetts office will focus much of their attention on the expected launch later this year of drug candidate Lymphoseek, a targeting agent used by surgeons to identify lymph nodes in patients with breast cancer or melanoma and to indicate [...]

[Read more of this report]


STERIS System 1E sales continue to lag earlier projections

Sterilization products maker STERIS (NYSE:STE) reported that shipments of its System 1E sterilizer continue to fall below the company’s earlier projections.The Mentor, Ohio-based company now projects that it’ll ship 4,000 System 1E units in its fiscal 2012, which is scheduled to end on March 31, company executives said Tuesday in a conference call to discuss [...]

[Read more of this report]


Older Posts »

Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Twitter Buzz

MedCity Jobs Board

Real Time Web Analytics